Form 4 for ACRV Acrivon Therapeutics, Inc.
Accepted 2024-04-19 00:00:00 ET · period of report 2024-04-17 · accession 0000905148-24-001186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-19 | 2024-04-17 | ACRV | Miller Mary | CLO | F - Tax | $10.34 | -558 | 39.9K | -1% | -$5,770 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-17 | F | D | 558 | $10.34 | 39,893 | D | — | — |